---
$id: https://graph.org.ai/products/commodity/51142429
$type: Product
source: UNSPSC
code: "51142429"
title: "Frovatriptan succinate"
class: "51142400"
classTitle: "Drugs used for vascular and migraine headaches"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Frovatriptan succinate

**UNSPSC Code**: 51142429
**Class**: [Drugs used for vascular and migraine headaches](Drugs used for vascular and migraine headaches.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a serotonin agonist with the molecular formula C14H17N3O.C4H6O4.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier D28J6W18HY, chemically known as 1h-carbazole-6-carboxamide, 2,3,4,9-tetrahydro-3-(methylamino)-, (r)-, butanedioate (1:1) but more generally known as frovatriptan succinate, which bears US NIH Compound Identifier 152944. European Medicines Agency schedules Frovatriptan succinate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB22174. Most nations, for tariff and trade purposes, schedule frovatriptan succinate under HS 29339990. As of Q4 2014, FROVATRIPTAN SUCCINATE remains US FDA's Preferred Term for this commodity. Frovatriptan succinate bears US NLM identifiers UMLS ID C1099777 and NCI Concept Code C47544. SMILES: CN[C@@H]1CCC2C(C3CC(CCC3[NH]2)C(=O)N)C1.C(CC(=O)O)C(=O)O.O.

